Association between Neutrophilic Granulocyte Percentage and Diabetes Mellitus in Cushing's Syndrome Patients: A Cross-Sectional Study
- PMID: 34880914
- PMCID: PMC8648481
- DOI: 10.1155/2021/9536730
Association between Neutrophilic Granulocyte Percentage and Diabetes Mellitus in Cushing's Syndrome Patients: A Cross-Sectional Study
Abstract
Background: Glucose metabolism is frequently impaired in patients with Cushing's syndrome (CS) due to chronic exposure to excess glucocorticoids. Inflammation plays an essential role in the pathophysiology of diabetes mellitus (DM). The present study aimed to investigate the potential associations of inflammatory blood cell parameters, including white blood cell (WBC) count, neutrophil count, neutrophilic granulocyte percentage (NEUT%), lymphocyte count (LYM), and lymphocyte proportion (LYM%), with diabetes mellitus in Cushing's syndrome patients.
Materials and methods: The cross-sectional study was conducted in Zhongshan Hospital of Fudan University, China. A total of 150 patients with Cushing's syndrome were retrospectively screened from 2017 to 2019. The demographic data, clinical data, and blood samples (lipids, adrenal, glucose, and inflammatory blood cell parameters) were recorded. Statistical analyses were carried out by using the SPSS software package, version 13.0.
Results: In this study, the prevalence of diabetes mellitus was 38.7% in patients with Cushing's syndrome. Patients with DM had higher WBC, neutrophil, NEUT% levels than patients without DM (p < 0.05). As the NEUT% increased, a stepwise increase in glucose and glycated hemoglobin (HbA1c) level was observed. In addition, in the multivariate logistic regression, NEUT% was a significant independent risk factor for DM, regardless of gender, age, body mass index (BMI), and triglyceride and 12 midnight cortisol (12 MN cortisol) level (OR = 2.542, 95% CI 1.337-4.835, p < 0.001).
Conclusions: In conclusion, elevated NEUT% level was linked to diabetes in patients with Cushing's syndrome. The neutrophilic granulocyte percentage may be referred to as a new predictor for diabetes in Cushing's syndrome patients.
Copyright © 2021 Baomin Wang et al.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.Endocrine. 2019 Apr;64(1):157-168. doi: 10.1007/s12020-018-1819-6. Epub 2018 Nov 22. Endocrine. 2019. PMID: 30467627 Free PMC article.
-
[Clinical features and outcomes of surgical versus conservative management in patients with subclinical Cushing's syndrome].Zhonghua Yi Xue Za Zhi. 2020 Sep 29;100(36):2834-2840. doi: 10.3760/cma.j.cn112137-20200213-00274. Zhonghua Yi Xue Za Zhi. 2020. PMID: 32988143 Chinese.
-
Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.Endocr J. 2016 Nov 30;63(11):1017-1023. doi: 10.1507/endocrj.EJ15-0748. Epub 2016 Aug 5. Endocr J. 2016. PMID: 27498594
-
Subclinical Cushing's syndrome.Endocrinol Metab Clin North Am. 2000 Mar;29(1):43-56. doi: 10.1016/s0889-8529(05)70115-8. Endocrinol Metab Clin North Am. 2000. PMID: 10732263 Review.
-
Management of diabetes mellitus in Cushing's syndrome.Neuroendocrinology. 2010;92 Suppl 1:82-5. doi: 10.1159/000314316. Epub 2010 Sep 10. Neuroendocrinology. 2010. PMID: 20829624 Review.
References
LinkOut - more resources
Full Text Sources
Research Materials